Skip to main content
SpringerLink
Log in

US Aptivus labelling updated with ICH warning

  • Correspondence
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Boehringer Ingelheim.Important safety information: intracranial hemorrhage in patients receiving Aptivus (Rm) (tipranavir) capsules. Company Communication: [6 pages], 30 Jun 2006. Available from: URL: http://www.fda.gov

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

US Aptivus labelling updated with ICH warning. React. Wkly. 1109, 4 (2006). https://doi.org/10.2165/00128415-200611090-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611090-00011

Keywords

Search

Navigation